Literature DB >> 630063

Quantitative determination of nifedipine in human plasma by selected ion monitoring.

S Higuchi, Y Shiobara.   

Abstract

A highly sensitive and specific method for the determination of nifedipine in plasma is described. Nifedipine was oxidized to its pyridine analogue with nitrous acid and determined by selected ion monitoring. Deuterium labeled nifedipine was used as an internal standard. Plasma levels as low as 5 ng ml-1 were measured. The usefulness of the method was demonstrated by obtaining plasma concentration curves for humans after an oral dose of 10 mg.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 630063     DOI: 10.1002/bms.1200050310

Source DB:  PubMed          Journal:  Biomed Mass Spectrom        ISSN: 0306-042X


  6 in total

1.  Pharmacokinetics of nifedipine derived from a new retard tablet formulation.

Authors:  A Avgerinos; J W Gorrod
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Oct-Dec       Impact factor: 2.441

Review 2.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

3.  Relationship between the antihypertensive effect and steady-state plasma concentration of nifedipine given alone or in combination with a beta-adrenoceptor blocking agent.

Authors:  O Lederballe Pedersen; C K Christensen; E Mikkelsen; K D Rämsch
Journal:  Eur J Clin Pharmacol       Date:  1980-10       Impact factor: 2.953

4.  Nifedipine serum concentration; effects upon blood pressure and heart rate in normotensive volunteers.

Authors:  T Nakashima; M Inoki; Y Nakanishi
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1984 Jan-Mar       Impact factor: 2.441

Review 5.  Clinical pharmacokinetics of verapamil, nifedipine and diltiazem.

Authors:  H Echizen; M Eichelbaum
Journal:  Clin Pharmacokinet       Date:  1986 Nov-Dec       Impact factor: 6.447

Review 6.  Calcium antagonists. Pharmacokinetic properties.

Authors:  R E Kates
Journal:  Drugs       Date:  1983-02       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.